Brainomix Teams With PFF to Test AI Lung CT Analysis With Patients
Image
Oxford – October 14, 2026 -- Brainomix has partnered with the Pulmonary Fibrosis Foundation (PFF) to test how patients and caregivers respond when its FDA-cleared, CE-marked e-Lung quantitative CT analysis is built into clinicians' assessment workflow for pulmonary fibrosis (PF) and other fibrotic interstitial lung diseases (ILD).
Patient research targets how CT metrics shape treatment conversations
The multi-phase initiative will examine how objective quantitative CT metrics could improve clinicians' understanding of disease change over time. It will also assess how patients experience and understand those insights.